Fralish, Zachary http://orcid.org/0000-0001-6293-1730
Chen, Ashley
Khan, Shaharyar
Zhou, Pei http://orcid.org/0000-0002-7823-3416
Reker, Daniel http://orcid.org/0000-0003-4789-7380
Article History
Accepted: 16 February 2024
First Online: 2 April 2024
Competing interests
: D.R. acts as a consultant to the pharmaceutical and biotechnology industry, as a mentor for Start2, and serves on the scientific advisory board of Areteia Therapeutics. S.K. is Chief Scientific Officer at Rivus. P.Z. is a scientific co-founder of Valanbio Therapeutics aiming at developing novel antibiotics.